Daily pill doubles survival time for pancreatic cancer patients
The pill, which has been developed by a team of researchers at a leading cancer research institute, targets specific cellular pathways involved in the progression of pancreatic tumors. Initial studies published in late 2023 indicate that patients taking the medication experienced a doubling in their median survival time compared to those receiving standard treatment. This … Read more